Takeshima T, , et al. J Headache Pain. 2022;23(1):24.
Takeshima T, Nakai M, Shibasaki Y, Ishida M, Kim BK, Ning X, et al.
Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients.
J Headache Pain. 2022;23(1):24.
https://www.ncbi.nlm.nih.gov/pubmed/35139816
2022/02/11
コメント
コメントを投稿